Pharmacokinetics and dosage regimen of enrofloxacin in buffalo bulls after intramuscular administration

Veterinary Research Communications

Volumn 23, Issue 8, 1999, Pages 501-505

  Verma, H K ^a   Pangawkar, G R ^a   Chaudhary, R K ^a   Srivastava, A K ^a  

^a PUNJAB AGRICULTURAL UNIVERSITY   (India)

Author keywords

Antibiotics; Buffalo; Disposition; Dosage; Enrofloxacin; Pharmacokinetics

Indexed keywords

ENROFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; BREEDING; BUFFALO; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; NONHUMAN;

ANIMAL HUSBANDRY; ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BUFFALOES; DRUG ADMINISTRATION SCHEDULE; FLUOROQUINOLONES; INJECTIONS, INTRAMUSCULAR; MALE; QUINOLONES;

ANIMALIA; BUBALUS;

EID: 0033373455     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006366507016     Document Type: Article

References (17)

1. Ahangar, A.A., 1998. Effect of fever on pharmacokinetics and dosage regimen of enrofloxacin in cow calves, (MVSc thesis, Punjab Agricultural University, Ludhiana, India)
2. Altreuther, P., 1987. Data on chemistry and toxicology of Baytril. Veterinary Medicine Review, 2, 87-89
3. Arret, B., Johnson, D.P. and Krishbaum, A., 1971. Outline of details for microbiological assay of antibiotics: Second Revision. Journal of Pharmaceutical Science, 60, 1689-1694
4. Baggot, J.D., 1977. Principles of drug disposition in domestic animals. In: J.D. Baggot (ed.), The Basis of Veterinary Clinical Pharmacology, (W.B. Saunders, Philadelphia), 144-189
5. Bauditz, R., 1990. Enrofloxacin - clinical evaluation in several animals. In: F. Siman, P. Lees and G. Semjen (eds), Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals, (University of Veterinary Science, Unipharma Co. Ltd, Budapest), 21-26
6. Cabanes, A., Arboix, M., Gracia, J.M. and Reign, F., 1992. Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. American Journal of Veterinary Research, 53, 2090-2093
7. Dowling, P.M., Wilson, R.C., Tyler, J.W. and Duran, S.H., 1995. Pharmacokinetics of ciprofloxacin in ponies. Journal of Veterinary Pharmacology and Therapeutics, 18, 7-12
8. Gandorfer, B., 1991. Pharmacokinetics of Baytril (enrofloxacin), particularly passage from blood to milk, (Inaugural dissertation, Tierarztliche Fakultat, Ludwig Maximilians-Universität, Munchen), 104
9. Gatne, M.M. and Ranade, V.V., 1996. Enrofloxacin - a new drug. The Blue Cross Book, 6, 26-28
10. Gibaldi, M. and Perrier, D., 1982. Appendix C: Method of residuals. Pharmacokinetics, (Marcel Dekker, New York), 433-444
11. Kuhn, H., 1993. Pharmacokinetic studies on the gyrase inhibitors enrofloxacin and ofloxacin, (Inaugural dissertation, Tierarztliche Fakultat, Ludwig Maximilians-Universität, Munchen), 214
12. Kung, K., Riond, J.L. and Wanner, M., 1993. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462-468
13. Prescott, J.F. and Yielding, K.M., 1990. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research, 54, 195-197
14. Scheer, M., 1987. Studies on the antimicrobial activity of Baytril. Veterinary Medicine Review, 2, 90-99
15. Steeve, G., Raymond, W.S. and Myriam, B., 1996. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. American Journal of Veterinary Research, 7, 1025-1030
16. Vancutsem, M., Babish, J.G. and Schwark, W.S., 1990. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Veterinarian, 80, 173-186
17. Zehe, V., 1990. Pharmacokinetics of DNA gyrase inhibitor enrofloxacin in horses, (Inaugural dissertation, Tierarztliche Hochschule, Hannover; CAB Abstract 060-05812)